BRX 0.25 (Rexulti 0.25 mg)
Generic Name: brexpiprazole
This pill with imprint "BRX 0.25" is Brown, Round and has been identified as Rexulti 0.25 mg. It is manufactured by Otsuka Pharmaceutical Co., Ltd. and Lundbeck.
Rexulti is used in the treatment of major depressive disorder; schizophrenia; depression and belongs to the drug class atypical antipsychotics. Rexulti 0.25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- brexpiprazole
- Imprint:
- BRX 0.25
- Strength:
- 0.25 mg
- Color:
- Brown
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Atypical antipsychotics
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Otsuka Pharmaceutical Co., Ltd. and Lundbeck
More about Rexulti (brexpiprazole)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 87 Reviews – Add your own review/rating
- Drug class: atypical antipsychotics
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
